Fund profile
Brightstone Venture Capital
United States
Leading
About
Brightstone Venture Capital is a venture capital firm based in Minneapolis, Minnesota, established in 1985. The firm focuses on early-growth stage investments in technology and life sciences sectors. With a strong track record, Brightstone manages multiple venture partnerships and currently oversees a $100 million fund aimed at supporting innovative startups. Brightstone's portfolio includes notable companies like VRChat, Celcuity, Bite Squad, and StemoniX, which have achieved significant milestones such as IPOs and major acquisitions. For instance, Bite Squad was sold to WAITR Holdings for $321 million, and StemoniX went public on NASDAQ under the ticker VYNT. The firm is led by experienced partners, including David Dalvey, Jeffrey Cowan, and Patrick O'Shaughnessy, who bring deep expertise in venture investing and entrepreneurship. Brightstone is known for its hands-on approach, providing strategic guidance and operational support to help portfolio companies scale and succeed. Brightstone Venture Capital has made 62 investments and has had 25 successful exits, showcasing their ability to identify and nurture high-potential startups. Their investments span various industries, including biotechnology, software, virtual reality, and medical technology.
Details
Highlights
$3M
Historical average check
$44M
Historical max check
July 2022
Last investment date
35
Investments
Healthtech & Wellness
Software & Apps
Fintech & Financial services
Social media
Biotech
Transportation & Mobility
Other
Showing 0 lists